Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilast (Otezla ) can reduce alcohol intake by more than half in people with severe alcohol use disorder.
February 27, 2023
LA JOLLA, CA A clinical trial carried out at Scripps Research has shown that apremilast, approved by the U.S. Food and Drug Administration (FDA) for the treatment of psoriasis, cuts alcohol intake by more than half in people with severe alcohol use disorder (AUD). Collaborators at Oregon Health and Science University (OHSU) and other institutions also showed that, in mice, apremilast boosts activity in an area of the brain known to be involved in AUD.
The research was published online ahead of print by the Journal of Clinical Investigation on January 19, 2023.
We're incredibly excited to have found a drug that has such a large effect size on alcohol consumption, and with such good tolerability and safety at the same time, says co-senior author Barbara Mason, PhD, the Pearson Family Chair and Director of the Pearson Center for Alcohol and Addiction Research at Scripps Research.
About 29.5 million Americans meet the criteria for AUD, which encompasses the conditions known as alcohol abuse, alcohol dependence and alcohol addiction. Fewer than 10% of people with the disorder get any treatment, and an even smaller number are prescribed medication to treat AUD.
Mason is the director of the Translational Opportunities group for the Integrative Neuroscience Initiative on Alcoholism-NeuroImmune (INIA-NeuroImmune), a multidisciplinary, collaborative consortium funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to study the underlying biology of alcohol use disorder. In her role with INIA-NeuroImmune, Mason reviews research conducted by basic scientists in the consortium, and then identifies the most promising drug candidates for clinical trials.
INIA-NeuroImmune collaborators pinpointed apremilast sold under the brand name Otezla as a drug with the potential to treat AUD. The drug was known to block a molecule known as PDE4, which plays important roles in both immune and brain cell function. While its use in treating psoriasis is due to its immune function, basic scientific studies in mice had suggested that blocking PDE4 in the brain could reduce alcohol intake.
Mason launched a phase 2 trial, carried out entirely at the Pearson Center for Alcoholism and Addiction Research at Scripps Research, to study apremilast in humans. Among available PDE4 inhibitor medications, Mason chose apremilast because it had fewer of the gastrointestinal side effects associated with earlier PDE4 inhibitors such as rolipram or ibudalast. The trial enrolled 51 paid adult volunteers with severe AUD, none of whom were actively trying to consume less alcohol. For 14 days, each person took a daily pill of either apremilast or a placebo.
On average, participants consumed about five alcoholic drinks per day at the start of the study. People who received the placebo still drank nearly five drinks each day, while those who took apremilast reduced their alcohol intake to only about two drinks per day. In addition, apremilast decreased the percent of days that participants were classified as heavy drinkers. People who took apremilast reported anecdotally that they felt little impulse to drink and lacked the desire for alcohol that they usually had. Moreover, the drug was well tolerated with no participants discontinuing treatment due to gastrointestinal side effects
In this study, we saw that apremilast worked in mice. It worked in different labs, and it worked in people. This is incredibly promising for treatment of addiction in general, says co-senior author Angela Ozburn, PhD, associate professor of behavioral neuroscience in the OHSU School of Medicine and a research biologist with the Portland VA Health Care System.
Even with drugs currently approved by the FDA for alcohol use disorder, we usually see smaller effect sizes, says Mason. It's very unusual to get results like this, particularly in a severely affected population. This will need to move to larger, broader clinical trials now, but with this study, I think we've shown that this is an incredibly promising drug for alcohol use disorder.
In addition to Mason and Ozburn, authors of the study, Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast, are Alan Beneze, Jessica Bess, Jenny Miller, Susan Quello, Amanda J. Roberts, Marisa Roberto, Farhad Shadan and Michael Skinner of Scripps Research; John C. Crabbe, Evan J. Firsick, Kolter B. Grigsby, Pamela Metten and Kayla G. Townsley of Oregon Health & Science University; Heather C. Aziz, Regina A. Mangieri and Richard A. Morrisett of The University of Texas at Austin; Howard C. Becker and Marcelo F. Lopez of Medical University of South Carolina; Toby K. Eisenstein and Joseph J. Meissler of Temple University; and John M. Light of Oregon Research Institute.
This work was supported by funding from the National Institutes of Health (AA016651, AA013519, AA010760, AA07468, and AA027692, U01 AA013498, DA013429, P60AA06420 U01AA025476); the US Department of Veterans Affairs Grants (BX000313, BX004699, and IK2 BX002488), and a gift from the John R. Andrews Family.
Neurological Disorders Neuroscience Mason, Barbara
Most recent headlines
16/12/2025
Hawkins has landed on Spotify, just in time for Stranger Things Season 5, Volume...
16/12/2025
Wherever you are, your favorite music and audio content should go seamlessly with you. That's why Spotify has partnered with NAVER Corp, Korea's leading...
16/12/2025
2025 Wrapped arrived bigger and bolder than ever. This year's experience is designed to be ultra personal and shareable, with new features like Wrapped Part...
16/12/2025
Three 12-kilowatt Advanced Electric Propulsion System thrusters, supplied by L3Harris Technologies, form the core of Gateway's propulsion system. Pictured i...
16/12/2025
The challenge facing America's defense industrial base is not just about speed - its about rebuilding the foundation that makes speed possible. Our nations ...
16/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
16/12/2025
SEVILLE, Spain Canal Sur, the public broadcasting service for Andalusia, Spain, has completed a total technology refresh based on Pebble's resilient, softwa...
16/12/2025
NEW YORK Teleprompting hardware provider Telescript International has acquired all software code and intellectual property previously owned by Telescript West. ...
16/12/2025
As cable operators face increased competition from 5G fixed wireless access providers, a new report from Ookla Research finds that T-Mobile is the FWA speed lea...
16/12/2025
Apple has announced a major upgrade to the Apple TV app for device owners outside the Apple ecosystem with news that the Apple TV app for Android now supports G...
16/12/2025
Space42 grows Direct-to-Device partner ecosystem through a Memorandum of Underst...
16/12/2025
16 Dec 2025
VEON Announces Release Date for Full Year and Fourth Quarter 2025 R...
16/12/2025
16 Dec 2025
VEON's Kyivstar Invests in Renewable Energy in Ukraine with Acq...
16/12/2025
Back to All News
Emma Appleton, Fares Fares, Frida Gustavsson and Jakob Oftebro...
16/12/2025
Back to All News
Docu-reality My Korean Boyfriend Gets a Trailer and Premiere D...
16/12/2025
Harmonic's XOS Advanced Media Processor Improves Streaming Video Quality and Boosts Viewer Engagement SAN JOSE, Calif. - Dec. 16, 2025 - Harmonic (NASDAQ: ...
16/12/2025
RT Sport Awards 2025 live on RT One and RT Player at 8:05pm on Saturday 20 December.
On Saturday 20 December live on RT One and RT Player at the earlier t...
16/12/2025
Singer -songwriter Brian Kennedy has been announced as the final celebrity dance...
15/12/2025
Harlem Globetrotters Celebrate 100th Anniversary With New Brand Campaign From Th...
15/12/2025
Top L-R: La Tierra Del Valor (The Home of the Brave), Mangittatuarjuk (The Gnawe...
15/12/2025
L3Harris will leverage 15 years of experience supporting the E-4B Nightwatch and...
15/12/2025
CONWAY, Ark. In a notable example of how the loss of federal funding is forcing public stations to make massive cuts and operational changes, the statewide pub...
15/12/2025
BOULDER, Colo. Public Media Venture Group (PMVG), Venture Technologies Group (VTG), and WQED have completed a multipart agreement that they say will significant...
15/12/2025
Cape Town, November 13, 2025 - SES and International artist and humanitarian, Fo...
15/12/2025
Luxembourg, December 15, 2025 - SES, a leading space solutions company, and Abra Group launched fast and reliable multi-orbit inflight connectivity service on t...
15/12/2025
How Rivian s Design Puts Drivers First-And Why That Matters Published on Dec 15, 2025 Categories: Business Solutions
LinkedIn Corporate Communications
Sha...
15/12/2025
Space42 and Cobham Satcom completed the full range of advanced terminals for the...
15/12/2025
15 Dec 2025
VEON's Beeline Kazakhstan Delivers First Starlink Direct to Cel...
15/12/2025
Andrew Mountbatten-Windsor finds himself the topic of year's cracker jokes
Oasis, David Harbour, Celebrity Traitors and Angela Rayner all feature in this y...
15/12/2025
Comscore Expands Cross-Platform Campaign Measurement to Include Audio and Social New capabilities strengthen cross-platform campaign reporting suite; CCR rebran...
15/12/2025
NVIDIA today announced it has acquired SchedMD - the leading developer of Slurm, an open-source workload management system for high-performance computing (HPC) ...
15/12/2025
RT .ie has reached one billion page views this year and is on track to finish 2025 2% ahead of last year. Average time spent on the site is up 3% on 2024, with ...
15/12/2025
Modern workflows showcase the endless possibilities of generative and agentic AI on PCs.
Of many, some examples include tuning a chatbot to handle product-supp...
13/12/2025
Powering Client Growth: Horizon Deepens Nielsen Partnership, Enabling More Effic...
13/12/2025
In a move that will help it offer more flexible and less costly programming options, YouTube TV has announced that it will be launching YouTube TV Plans with mo...
13/12/2025
SINGAPORE Magna Systems has designed, built and completed what is believed to be the first full UHD and IP-based OB truck in Southeast Asia for a Singapore medi...
12/12/2025
SVG Summit 2025 Preview: Everything You Need to Know for Next Week's Big Sho...
12/12/2025
Hailey Gates at the Atropia premiere (photo by George Pimentel / Shutterstock for Sundance Film Festival)...
12/12/2025
Last month, Spotify announced a new collaboration with the ATP Tour, the global governing body of men's professional tennis, aimed at bringing the next gene...
12/12/2025
CONWAY, Ark. In a notable example of how the elimination of Federal federal funding is forcing public stations to make massive cuts and changes in the way they...
12/12/2025
Wisycom and DPA Microphones announce the appointment of Ren Moerch as Group Product Director, Wireless, a strategic leadership role that will guide the combine...
12/12/2025
SMPTE , the home of media professionals, technologists, and engineers, in conjuncture with the European Broadcasting Union (EBU) and the Entertainment Technolog...
12/12/2025
Keepit, the vendor-independent, cloud-native data protection provider, today announced a strategic go-to-market relationship in Poland with Ingram Micro, a lead...
12/12/2025
Atomos announced the immediate availability of a new firmware update for its Ninja TX GO and Ninja TX monitor-recorders, unlocking Open Gate 48P RAW recording w...
12/12/2025
Professional Wireless Systems (PWS) once again played a critical role in delivering flawless wireless coordination and support at the 2025 Latin Grammy Awards a...
12/12/2025
The Alliance for IP Media Solutions (AIMS), together with the Video Services Forum (VSF), the Advanced Media Workflow Association (AMWA) and the European Broadc...
12/12/2025
DHD audio will demonstrate the latest additions to its range of digital audio production solutions on Booth 321 in Hall B6 at Hamburg Open 2026. The show will b...
12/12/2025
Chaos today announces the release of V-Ray for Blender, update 2, bringing its award-winning rendering technology to even more Blender users by adding support f...
12/12/2025
Lighting specialist UltraLEDs has launched Precision LED Tape, a high-CRI lighting solution designed specifically for professional film, TV, and studio use.
P...
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilast (Otezla ) can reduce alcohol intake by more than half in people with severe alcohol use disorder.
